Request for Covid-19 Impact Assessment of this Report
The United States Rofecoxib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rofecoxib market, reaching US$ million by the year 2028. As for the Europe Rofecoxib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rofecoxib players cover Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, and Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rofecoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral Suspension.
Tablet-Form
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rofecoxib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Rofecoxib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Rofecoxib by Country/Region, 2017, 2022 & 2028
2.2 Rofecoxib Segment by Type
2.2.1 Oral Suspension.
2.2.2 Tablet-Form
2.3 Rofecoxib Sales by Type
2.3.1 Global Rofecoxib Sales Market Share by Type (2017-2022)
2.3.2 Global Rofecoxib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Rofecoxib Sale Price by Type (2017-2022)
2.4 Rofecoxib Segment by Application
2.4.1 Osteoarthritis
2.4.2 Rheumatoid Arthritis
2.4.3 Juvenile Rheumatoid Arthritis
2.4.4 Acute Pain Conditions
2.4.5 Migraine
2.4.6 Dysmenorrhea
2.5 Rofecoxib Sales by Application
2.5.1 Global Rofecoxib Sale Market Share by Application (2017-2022)
2.5.2 Global Rofecoxib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Rofecoxib Sale Price by Application (2017-2022)
3 Global Rofecoxib by Company
3.1 Global Rofecoxib Breakdown Data by Company
3.1.1 Global Rofecoxib Annual Sales by Company (2020-2022)
3.1.2 Global Rofecoxib Sales Market Share by Company (2020-2022)
3.2 Global Rofecoxib Annual Revenue by Company (2020-2022)
3.2.1 Global Rofecoxib Revenue by Company (2020-2022)
3.2.2 Global Rofecoxib Revenue Market Share by Company (2020-2022)
3.3 Global Rofecoxib Sale Price by Company
3.4 Key Manufacturers Rofecoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rofecoxib Product Location Distribution
3.4.2 Players Rofecoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rofecoxib by Geographic Region
4.1 World Historic Rofecoxib Market Size by Geographic Region (2017-2022)
4.1.1 Global Rofecoxib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Rofecoxib Annual Revenue by Geographic Region
4.2 World Historic Rofecoxib Market Size by Country/Region (2017-2022)
4.2.1 Global Rofecoxib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Rofecoxib Annual Revenue by Country/Region
4.3 Americas Rofecoxib Sales Growth
4.4 APAC Rofecoxib Sales Growth
4.5 Europe Rofecoxib Sales Growth
4.6 Middle East & Africa Rofecoxib Sales Growth
5 Americas
5.1 Americas Rofecoxib Sales by Country
5.1.1 Americas Rofecoxib Sales by Country (2017-2022)
5.1.2 Americas Rofecoxib Revenue by Country (2017-2022)
5.2 Americas Rofecoxib Sales by Type
5.3 Americas Rofecoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rofecoxib Sales by Region
6.1.1 APAC Rofecoxib Sales by Region (2017-2022)
6.1.2 APAC Rofecoxib Revenue by Region (2017-2022)
6.2 APAC Rofecoxib Sales by Type
6.3 APAC Rofecoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rofecoxib by Country
7.1.1 Europe Rofecoxib Sales by Country (2017-2022)
7.1.2 Europe Rofecoxib Revenue by Country (2017-2022)
7.2 Europe Rofecoxib Sales by Type
7.3 Europe Rofecoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rofecoxib by Country
8.1.1 Middle East & Africa Rofecoxib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Rofecoxib Revenue by Country (2017-2022)
8.2 Middle East & Africa Rofecoxib Sales by Type
8.3 Middle East & Africa Rofecoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rofecoxib
10.3 Manufacturing Process Analysis of Rofecoxib
10.4 Industry Chain Structure of Rofecoxib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rofecoxib Distributors
11.3 Rofecoxib Customer
12 World Forecast Review for Rofecoxib by Geographic Region
12.1 Global Rofecoxib Market Size Forecast by Region
12.1.1 Global Rofecoxib Forecast by Region (2023-2028)
12.1.2 Global Rofecoxib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rofecoxib Forecast by Type
12.7 Global Rofecoxib Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Rofecoxib Product Offered
13.1.3 Merck Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Chengdu Meinkai Chemical Co. LTD
13.2.1 Chengdu Meinkai Chemical Co. LTD Company Information
13.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Offered
13.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Chengdu Meinkai Chemical Co. LTD Main Business Overview
13.2.5 Chengdu Meinkai Chemical Co. LTD Latest Developments
13.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
13.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
13.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Offered
13.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business Overview
13.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Latest Developments
13.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
13.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
13.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Offered
13.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business Overview
13.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Latest Developments
13.5 Pfizer
13.5.1 Pfizer Company Information
13.5.2 Pfizer Rofecoxib Product Offered
13.5.3 Pfizer Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Main Business Overview
13.5.5 Pfizer Latest Developments
13.6 Tremeau
13.6.1 Tremeau Company Information
13.6.2 Tremeau Rofecoxib Product Offered
13.6.3 Tremeau Rofecoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Tremeau Main Business Overview
13.6.5 Tremeau Latest Developments
14 Research Findings and Conclusion
Table 1. Rofecoxib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Rofecoxib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Suspension.
Table 4. Major Players of Tablet-Form
Table 5. Global Rofecoxib Sales by Type (2017-2022) & (MT)
Table 6. Global Rofecoxib Sales Market Share by Type (2017-2022)
Table 7. Global Rofecoxib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Rofecoxib Revenue Market Share by Type (2017-2022)
Table 9. Global Rofecoxib Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Rofecoxib Sales by Application (2017-2022) & (MT)
Table 11. Global Rofecoxib Sales Market Share by Application (2017-2022)
Table 12. Global Rofecoxib Revenue by Application (2017-2022)
Table 13. Global Rofecoxib Revenue Market Share by Application (2017-2022)
Table 14. Global Rofecoxib Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Rofecoxib Sales by Company (2020-2022) & (MT)
Table 16. Global Rofecoxib Sales Market Share by Company (2020-2022)
Table 17. Global Rofecoxib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Rofecoxib Revenue Market Share by Company (2020-2022)
Table 19. Global Rofecoxib Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Rofecoxib Producing Area Distribution and Sales Area
Table 21. Players Rofecoxib Products Offered
Table 22. Rofecoxib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Rofecoxib Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Rofecoxib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Rofecoxib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Rofecoxib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Rofecoxib Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Rofecoxib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Rofecoxib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Rofecoxib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Rofecoxib Sales by Country (2017-2022) & (MT)
Table 34. Americas Rofecoxib Sales Market Share by Country (2017-2022)
Table 35. Americas Rofecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Rofecoxib Revenue Market Share by Country (2017-2022)
Table 37. Americas Rofecoxib Sales by Type (2017-2022) & (MT)
Table 38. Americas Rofecoxib Sales Market Share by Type (2017-2022)
Table 39. Americas Rofecoxib Sales by Application (2017-2022) & (MT)
Table 40. Americas Rofecoxib Sales Market Share by Application (2017-2022)
Table 41. APAC Rofecoxib Sales by Region (2017-2022) & (MT)
Table 42. APAC Rofecoxib Sales Market Share by Region (2017-2022)
Table 43. APAC Rofecoxib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Rofecoxib Revenue Market Share by Region (2017-2022)
Table 45. APAC Rofecoxib Sales by Type (2017-2022) & (MT)
Table 46. APAC Rofecoxib Sales Market Share by Type (2017-2022)
Table 47. APAC Rofecoxib Sales by Application (2017-2022) & (MT)
Table 48. APAC Rofecoxib Sales Market Share by Application (2017-2022)
Table 49. Europe Rofecoxib Sales by Country (2017-2022) & (MT)
Table 50. Europe Rofecoxib Sales Market Share by Country (2017-2022)
Table 51. Europe Rofecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Rofecoxib Revenue Market Share by Country (2017-2022)
Table 53. Europe Rofecoxib Sales by Type (2017-2022) & (MT)
Table 54. Europe Rofecoxib Sales Market Share by Type (2017-2022)
Table 55. Europe Rofecoxib Sales by Application (2017-2022) & (MT)
Table 56. Europe Rofecoxib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Rofecoxib Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Rofecoxib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Rofecoxib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Rofecoxib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Rofecoxib Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Rofecoxib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Rofecoxib Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Rofecoxib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Rofecoxib
Table 66. Key Market Challenges & Risks of Rofecoxib
Table 67. Key Industry Trends of Rofecoxib
Table 68. Rofecoxib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Rofecoxib Distributors List
Table 71. Rofecoxib Customer List
Table 72. Global Rofecoxib Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Rofecoxib Sales Market Forecast by Region
Table 74. Global Rofecoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Rofecoxib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Rofecoxib Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Rofecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Rofecoxib Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Rofecoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Rofecoxib Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Rofecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Rofecoxib Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Rofecoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Rofecoxib Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Rofecoxib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Rofecoxib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Rofecoxib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Rofecoxib Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Rofecoxib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Rofecoxib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Rofecoxib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Rofecoxib Product Offered
Table 94. Merck Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Chengdu Meinkai Chemical Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 98. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Offered
Table 99. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Chengdu Meinkai Chemical Co. LTD Main Business
Table 101. Chengdu Meinkai Chemical Co. LTD Latest Developments
Table 102. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 103. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Offered
Table 104. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business
Table 106. Wuhan Xinxin Jiali Biotechnology Co. LTD Latest Developments
Table 107. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 108. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Offered
Table 109. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table 111. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Latest Developments
Table 112. Pfizer Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Rofecoxib Product Offered
Table 114. Pfizer Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Tremeau Basic Information, Rofecoxib Manufacturing Base, Sales Area and Its Competitors
Table 118. Tremeau Rofecoxib Product Offered
Table 119. Tremeau Rofecoxib Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. Tremeau Main Business
Table 121. Tremeau Latest Developments
List of Figures
Figure 1. Picture of Rofecoxib
Figure 2. Rofecoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rofecoxib Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Rofecoxib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Rofecoxib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Suspension.
Figure 10. Product Picture of Tablet-Form
Figure 11. Global Rofecoxib Sales Market Share by Type in 2021
Figure 12. Global Rofecoxib Revenue Market Share by Type (2017-2022)
Figure 13. Rofecoxib Consumed in Osteoarthritis
Figure 14. Global Rofecoxib Market: Osteoarthritis (2017-2022) & (MT)
Figure 15. Rofecoxib Consumed in Rheumatoid Arthritis
Figure 16. Global Rofecoxib Market: Rheumatoid Arthritis (2017-2022) & (MT)
Figure 17. Rofecoxib Consumed in Juvenile Rheumatoid Arthritis
Figure 18. Global Rofecoxib Market: Juvenile Rheumatoid Arthritis (2017-2022) & (MT)
Figure 19. Rofecoxib Consumed in Acute Pain Conditions
Figure 20. Global Rofecoxib Market: Acute Pain Conditions (2017-2022) & (MT)
Figure 21. Rofecoxib Consumed in Migraine
Figure 22. Global Rofecoxib Market: Migraine (2017-2022) & (MT)
Figure 23. Rofecoxib Consumed in Dysmenorrhea
Figure 24. Global Rofecoxib Market: Dysmenorrhea (2017-2022) & (MT)
Figure 25. Global Rofecoxib Sales Market Share by Application (2017-2022)
Figure 26. Global Rofecoxib Revenue Market Share by Application in 2021
Figure 27. Rofecoxib Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Rofecoxib Revenue Market Share by Company in 2021
Figure 29. Global Rofecoxib Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Rofecoxib Revenue Market Share by Geographic Region in 2021
Figure 31. Global Rofecoxib Sales Market Share by Region (2017-2022)
Figure 32. Global Rofecoxib Revenue Market Share by Country/Region in 2021
Figure 33. Americas Rofecoxib Sales 2017-2022 (MT)
Figure 34. Americas Rofecoxib Revenue 2017-2022 ($ Millions)
Figure 35. APAC Rofecoxib Sales 2017-2022 (MT)
Figure 36. APAC Rofecoxib Revenue 2017-2022 ($ Millions)
Figure 37. Europe Rofecoxib Sales 2017-2022 (MT)
Figure 38. Europe Rofecoxib Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Rofecoxib Sales 2017-2022 (MT)
Figure 40. Middle East & Africa Rofecoxib Revenue 2017-2022 ($ Millions)
Figure 41. Americas Rofecoxib Sales Market Share by Country in 2021
Figure 42. Americas Rofecoxib Revenue Market Share by Country in 2021
Figure 43. United States Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Rofecoxib Sales Market Share by Region in 2021
Figure 48. APAC Rofecoxib Revenue Market Share by Regions in 2021
Figure 49. China Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Rofecoxib Sales Market Share by Country in 2021
Figure 56. Europe Rofecoxib Revenue Market Share by Country in 2021
Figure 57. Germany Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Rofecoxib Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Rofecoxib Revenue Market Share by Country in 2021
Figure 64. Egypt Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Rofecoxib Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Rofecoxib in 2021
Figure 70. Manufacturing Process Analysis of Rofecoxib
Figure 71. Industry Chain Structure of Rofecoxib
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...